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Cordyceps (Cordyceps militaris) exhibits many biological activities including antioxidant,
inhibition of inflammation, cancer prevention, hypoglycemic, and antiaging properties,
etc. However, a majority of studies involving C. militaris have focused only on in vitro and
animal models, and there is a lack of direct translation and application of study results to
clinical practice (e.g., health benefits). In this study, we investigated the regulatory effects
of C. militaris micron powder (3 doses) on the human immune system. The study results
showed that administration of C. militaris at various dosages reduced the activity of cyto-
kines such as eotaxin, fibroblast growth factor-2, GRO, and monocyte chemoattractant
protein-1. In addition, there was a significant decrease in the activity of various cytokines,
including GRO, sCD40L, and tumor necrosis factor-a, and a significant downregulation of
interleukin-12(p70), interferon-g inducible protein 10, and macrophage inflammatory
protein-1b activities, indicating that C. militaris at all three dosages downregulated the
activity of cytokines, especially inflammatory cytokines and chemokines. Different dos-
ages of C. militaris produced different changes in cytokines.
Copyright ª 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license. 1. Introduction
Cordyceps militaris, also known as north Cordyceps sinensis, is
the most common species of the genus Cordyceps (Division:nce and Technology, Nan
. Zhao).
ministration, Taiwan. PublAscomycotina; Order: Hypocreales; Family: Clavicepitaceae)
[1]. The bioactive components in C. militaris such as cordy-
cepin, cordyceps polysaccharide, cordycepic acid, and su-
peroxide dismutase [2] have been reported to possess
various biological properties, including antioxidant [3],jing Agricultural University, Nanjing 210095, China.
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hibition of inflammation [7]. Although many studies have
documented the biological activity of C. militaris, most of
these have focused on in vitro or animal models, which are
unable to reveal the impact of these components on im-
mune regulation because of the cutoff of communication
between immune cells.
In elucidating the action mechanism of the phytochem-
icals in C. militaris, we conducted a human study to gain a
better understanding of regulatory effects of this special
Cordyceps species. Twelve young volunteers were selected as
participants for oral administration of C. militaris submicron
powder. A liquid chip scanner was used to determine the
content changes of 39 cytokines and to explore regulatory
functions and signal pathways of C. militaris with respect to
the immune system; in addition we also evaluated its
antitumor activity. A cell communication network of the
human immune system was established based on the
experimental data.2. Methods
2.1. Materials
C. militaris was purchased from Yancheng Shennong Func-
tional Food Co., Ltd., dried, and crushed into a powder form
with a particle size smaller than 48 mm in diameter. A 3K15
high-speed refrigerated centrifuge was purchased from Sigma
Co. (St. Louis, MO, USA). A light biochemical incubator was
purchased fromDonglian Ltd. Co. (Harbin, China). The human
kit with 96 enzyme-labeled plates and the liquid chip scanner
were purchased from Millipore Corporation (Billerica, MA,
USA).
2.2. Participants
Volunteers for the study were five male and seven female
healthy college students aged from 20 years to 21 years; the
averagemale and female bodyweightswere 65 2 kg and 48
2 kg, respectively. The body mass index of male and female
volunteers was in the range of 21.14e21.46 and 17.96e18.36,
respectively. All volunteers signed informed, responsibility,
and safety agreements and were randomly divided into three
dosage groups of four students. All experiments were con-
ducted according to the Declaration of Helsinki and all
experimental protocols were approved by the ethical com-
mittee for human trials of the College of Biotechnology and
Food Science, Tianjin University of Commerce (Tianjin,
China). The volunteers were required to follow a schedule of
regular and normal hours of work and rest, as well as strict
restrictions on strenuous exercise, cigarettes smoking, or
alcohol. Except for nonfunctional meals provided for these
volunteers, any other functional foods, drugs, or beverages
were prohibited. During the study period, all volunteers
stayed in a relaxed environment to protect them from sources
of stress [8].
During the 2-day period of experimental duration, the
volunteers were provided with unbiased meals on the 1st day
andwith the samemeals with the addition of the test foods onthe 2nd day. Blood samples were collected at 2 PM every day,
incubated at 4 C for 16 hours, centrifuged at 3200g for 10
minutes, and stored at 70 C for future use. Test results from
the 1st day were used as the control.
2.3. Administration dosages and methods
In this study, the submicron powder at high,medium, and low
dosages (3, 1.5, and 0.5 g) was mixed with water to form a
paste, respectively. The paste was steamed for 15 minutes
before oral administration to the volunteers.
2.4. Cytokine detection
AMillipore human kit with 96-well enzyme-labeled plateswas
used to detect the following cytokines: epidermal growth
factor (EGF), eotaxin, fibroblast growth factor-2 (FGF-2), Flt-3L,
fractalkine, granulocyte-colony stimulating factor (G-CSF),
granulocyte-macrophage colony-stimulating factor (GM-CSF),
growth regulated oncogene (GRO), interferon-a2 (IFN-a2), IFN-
g, interleukin-1a (IL-1a), IL-1b, IL-1ra, IL-2, IL-3, IL-4, IL-5, IL-6,
IL-7, IL-8, IL-9, IL-10, IL-12(p40), IL-12(p70), IL-13, IL-15, IL-17,
IFN-g inducible protein 10 (IP-10), monocyte chemo-
attractant protein-1 (MCP-1), MCP-3, macrophage-derived
chemokine (MDC), macrophage inflammatory protein-1a
(MIP-1a), MIP-1b, sCD40L, sIL-2Ra, transforming growth fac-
tor-a (TGF-a), tumor necrosis factor-a (TNF-a), TNF-b, and
vascular endothelial growth factor (VEGF). The content-
change rates of these cytokines can be expressed using
following equation:




SPSS version 11.5 (SPSS Inc., Chicago, IL, USA) was used for
statistical analysis of experimental results using t test. Sig-
nificant differences or extreme significant differences were
considered at p < 0.05 and p < 0.01, respectively.3. Results
3.1. Impact of low dosage of C. militaris on cytokines
Following the administration of C. militaris at the 0.5 g dosage,
no obvious changes were observed in 19 cytokines, including
IL-1a, IL-1b, IL-1ra, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-
12(p40), IL-13, IL-15, IL-17, MCP-3, MIP-1a, sIL-2Ra, and TNF-
b, whereas the concentrations of IFN-g in blood samples taken
from the volunteers increased from the 1st day to the 2nd day,
which suggested upregulation of IFN-g. By contrast, the con-
centrations of EGF, eotaxin, FGF-2, Flt-3L, fractalkine, G-CSF,
GM-CSF, GRO, IFN-a2, IL-8, IL-10, IL-12(p70), IP-10, MCP-1,
MDC, MIP-1b, sCD40L, TGF-a, TNF-a, and VEGF in blood sam-
ples from the volunteers decreased from the 1st day to the 2nd
day, which suggested that these cytokines were down-
regulated (Fig. 1).
Results of the t test revealed a significant decrease in
eotaxin, FGF-2, GRO, andMCP-1, suggesting that C. militaris at a
Fig. 1 e Administration of Cordyceps militaris at the 0.5 g
dosage and the rate of change in the concentration of
different cytokines. 1. Epidermal growth factor; 2. Eotaxin;
3. Fibroblast growth factor-2; 4. Flt-3L; 5. Fractalkine; 6.
Granulocyte-colony stimulating factor; 7. Granulocyte-
macrophage colony-stimulating factor; 8. GRO; 9.
Interferon-a2 (IFN-a2); 10. IFN-g; 11. Interleukin-1a (IL-1a);
12. IL-1b; 13. IL-1ra; 14. IL-2; 15. IL-3; 16. IL-4; 17. IL-5; 18.
IL-6; 19. IL-7; 20. IL-8; 21. IL-9; 22. IL-10; 23. IL-12(p40); 24.
IL-12(p70); 25. IL-13; 26. IL-15; 27. IL-17; 28. IFN-g inducible
protein 10; 29. Monocyte chemoattractant protein-1 (MCP-
1); 30. MCP-3; 31. Macrophage-derived chemokine; 32.
Macrophage inflammatory protein-1a (MIP-1a); 33. MIP-1b;
34. sCD40L; 35. sIL-2Ra; 36. Transforming growth factor-a;
37. Tumor necrosis factor-a (TNF-a); 38. TNF-b; and 39.
Vascular endothelial growth factor. Similarly hereinafter.
Fig. 2 e Administration of Cordyceps militaris at the 1.5 g
dosage and the rate of change in the concentration of
different cytokines.
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dramatically (Table 1).3.2. Impact of medium dosages of C. militaris on
cytokines
The administration of C. militaris at a dosage of 1.5 g produced
no observable changes in Flt-3L, IL-1b, IL-1ra, IL-2, IL-3, IL-4, IL-
5, IL-7, IL-9, IL-12(p70), IL-13, IL-15, IL-17, IP-10, MDC, or TNF-b,
whereas the concentrations of FGF-2, IL-10, IL-12(p40), MCP-3,
sIL-2Ra, and VEGF in blood samples from the volunteers were
much higher on the 2nd day, suggesting that these cytokines
were upregulated (Fig. 2). In addition, the concentrations ofTable 1 e Cytokines exhibiting significant changes after Cordy
Cytokines CControl/(pg/mL) CExp
Eotaxin 52.3 55.7 67.8 75.5 42.6 18
FGF-2 34.9 3.8 36.5 15.3 8.0 3
GRO 428 355 149 438 409 210
MCP-1 105 100 155 226 78.6 61
*p < 0.05, significant difference.
**p < 0.01, extreme significant difference.
FGF-2 ¼ fibroblast growth factor-2; MCP-1 ¼ monocyte chemoattracta
hereinafter.EGF, eotaxin, fractalkine, G-CSF, GM-CSF, GRO, IFN-a2, IFN-g,
IL-1a, IL-6, IL-8, MCP-1, MIP-1a, MIP-1b, sCD40L, TGF-a, and
TNF-a in blood samples from the volunteers decreased on the
2nd day, suggesting that these cytokines were downregulated.
Results of the t test revealed a significant decrease in GRO,
sCD40L, and TNF-a levels, which indicated that C. militaris at
a dosage of 1.5 g can downregulate these three cytokines
(Table 2).3.3. Impact of high dosages of C. militaris on
cytokines
The administration of C. militaris at a dosage of 3.0 g did not
result in obvious changes in Flt-3L, IFN-g, IL-1a, IL-1b, IL-1ra,
IL-3, IL-5, IL-6, IL-7, IL-9, IL-12(p40), IL-13, IL-17, MDC, MIP-1a,
sIL-2Ra, or TNF-b, whereas the concentrations of IL-4, IL-8,
and IL-15 in blood samples from the volunteers were much
higher on the 2nd day compared with that of the 1st day, sug-
gesting that these cytokines were upregulated (Fig. 3). How-
ever, the concentrations of EGF, eotaxin, FGF-2, fractalkine, G-
CSF, GM-CSF, GRO, IFN-a2, IL-2, IL-10, IL-12(p70), IP-10, MCP-1,
MCP-3, MIP-1b, sCD40L, TGF-a, TNF-a, and VEGF in blood
samples from the volunteers were lower on the 2nd day, which
suggested that these cytokines were downregulated.
Results of the t test revealed a significant decrease in IL-
12(p70), IP-10, MCP-1, and MIP-1b levels, indicating that C.ceps militaris administration at a dosage of 0.5 g.
erimental/(pg/mL) Average change rate/% p
.6 24.2 55.7 1.095* 0.052Y
.49 17.3 5.9 1.538* 0.095Y
66.7 309 0.597** 0.045Y
.1 111 154 0.459** 0.018Y
nt protein-1; Y ¼ decrease in the mean concentration. Similarly
Table 2 e Cytokines exhibiting significant changes after Cordyceps militaris administration at a dosage of 1.5 g.
Cytokines CControl/(pg/mL) CExperimental/(pg/mL) Average change rate/% p
GRO 519 483 340 340 105 153 156 232 1.327* 0.022Y
sCD40L 24,017 24,017 24,017 18,756 5454 24,017 14,456 8070 1.347** 0.084Y
TNF-a 3.7 4.4 8.4 2.2 1.8 3.9 5.8 1.5 0.525** 0.065Y
TNF-a ¼ tumor necrosis factor-a.
Fig. 3 e Administration of Cordyceps militaris at the 3.0 g
dosage and the rate of change in the concentration of
different cytokines.
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kines (Table 3).4. Discussion
In this study, the effects of administering C. militaris at low,
medium, and high dosages (0.5 g, 1.5 g, and 3.0 g, respectively)
were analyzed. Downregulation by C. militaris was observed
for different chemokines at all three dosages, including
eotaxin, FGF-2, GRO, and MCP-1 at low dosage; GRO, sCD40L,
and TNF-a at medium dosage; and IL-12(p70), IP-10, MCP-1,
and MIP-1b at high dosage. This regulatory effect is impor-
tant because chemokines play important physiological and
pathological roles in many diseases, including inflammation,
cancer, cancer metastasis, autoimmune diseases, hypersen-
sitivity, acquired immunodeficiency syndrome, and other
diseases associated with the involvement of chemokines andTable 3 e Cytokines exhibiting significant changes after Cordy
Cytokines CControl/(pg/mL) CExp
IL-12(p70) 1.7 1.1 2.2 1.9 1 0
IP-10 502 497 358 575 435 180
MCP-1 127 101 80.7 129 87.9 91
MIP-1b 43.5 40.3 25.9 5.7 26.9 21
IL-12(p70)¼ interleukin-12(p70); IP-10¼ interferon-g inducible protein 10;
inflammatory protein-1b.their receptors [9e14]. C. militaris at low and medium dosages
was observed to downregulate the expression of GRO, which
can promote the growth of epithelial cells and endothelial
cells [15], whereas at the medium dosage C. militaris exerted a
major influence on TNFs, such as sCD40L and TNF-a. TNF-a
can bind to a specific receptor on the surface of the cell
membrane to induce growth, differentiation, apoptosis, and
inflammation [16]. At higher dosages, C. militaris significantly
decreased the levels of IP-10 and MIP-1b. The concentration of
IP-10, which originates in monocytes/macrophages and T
cells, has been observed to increase in the neural system,
liver, and spleen as an inflammatory response to virus infec-
tion, which is a consequence of immune response to pathogen
invasion. However, recent studies have reported other factors
that may contribute to excessive inflammatory responses and
chemostatic effects, including diet and nutrition, which may
lead to transplant rejection [11]. The chemokine MIP-1b has
been found to regulate the migration of dendritic cells. A
previous study demonstrated that increased and decreased
expressions of MIP-1bwere related to the early and late stages
of colon cancer, respectively [17]. The administration of C.
militaris at both low and high dosages was also observed to
downregulate cytokine MCP-1. MCP-1 is the initial factor
associated with inflammation, and can form a cascade reac-
tion or mediate excessive inflammatory response by inducing
and regulating other inflammatory factors [18]. MCP-1 can
also boost the growth, survival, and migration of tumor cells
[19]. Results of this study indicate that C. militaris can exhibit
antitumor functions by downregulating the activity of these
cytokines.
In conclusion, we have demonstrated that the consump-
tion of C. militaris at three dosages can significantly reduce the
concentrations of cytokines, resulting in downregulation of
the immune system in the body. Different dosages of C. mili-
taris produced significant changes in different cytokines and
in cell communication. The strongest immunoregulatory role
of C. militaris appeared to occur with administration of the
medium dosage. These results suggest that C. militaris can
downregulate the immune system by reducing inflammatoryceps militaris administration at a dosage of 3.0 g.
erimental/(pg/mL) Average change rate/% p
.92 1.7 1.5 0.364* 0.026Y
298 450 0.599** 0.099Y
.4 70.2 87.6 0.293** 0.064Y
.4 23.9 1.86 0.912** 0.097Y
MCP-1¼monocyte chemoattractant protein-1; MIP-1b¼macrophage
j o u r n a l o f f o o d and d ru g an a l y s i s 2 2 ( 2 0 1 4 ) 4 6 3e4 6 7 467chemokines such as IP-10, MCP-1, and eotaxin, which can in
turn induce the migration of immune cells including macro-
phages and monocytes to the infection locations under in-
flammatory environments as well as by stimulating the
secretion of TNF-a and by the activation of nuclear factor-kB.
However, the significant reduction of TNF-a also suggests
decreased activity of macrophages and monocytes. All of
these results indicate that C. militaris at the various dosages
can reduce the excessive immune responses, which is ex-
pected to produce beneficial effects against some diseases
resulting from appropriate diet or autoimmunity, including an
inhibitory role in tumorigenesis.Conflicts of interest
All contributing authors declare no conflicts of interest.
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